PIRCHER, CHIARA CARLOTTA
 Distribuzione geografica
Continente #
EU - Europa 221
AS - Asia 58
NA - Nord America 38
Totale 317
Nazione #
DE - Germania 172
US - Stati Uniti d'America 38
CN - Cina 20
SG - Singapore 19
IT - Italia 15
GB - Regno Unito 11
IE - Irlanda 7
IN - India 7
ID - Indonesia 6
RU - Federazione Russa 5
SE - Svezia 5
HK - Hong Kong 3
FI - Finlandia 2
CH - Svizzera 1
FR - Francia 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
Totale 317
Città #
Frankfurt am Main 164
Singapore 15
Southend 9
Milan 8
Dublin 7
Jakarta 6
Santa Clara 5
Chandler 4
Hyderabad 3
Beijing 2
Bengaluru 2
Boston 2
Eitensheim 2
Hong Kong 2
Munich 2
New York 2
Nuremberg 2
Princeton 2
Shanghai 2
Amsterdam 1
Ashburn 1
Atlanta 1
Berlin 1
Columbus 1
Des Moines 1
Fuzhou 1
Helsinki 1
Lappeenranta 1
London 1
Los Angeles 1
Paris 1
Phoenix 1
Redmond 1
Reykjavik 1
Romford 1
Seoul 1
Tokyo 1
Upper Marlboro 1
Xiamen 1
Zurich 1
Totale 262
Nome #
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 115
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 102
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 87
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non–Small-Cell Lung Cancer With Novel Driver Alterations 18
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 4
Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review 1
Totale 327
Categoria #
all - tutte 1.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 1 0 4 2
2021/202224 1 3 2 1 2 4 2 1 4 0 2 2
2022/202335 2 0 0 2 3 9 1 2 3 1 10 2
2023/2024146 2 2 3 2 10 7 22 19 9 25 23 22
2024/2025115 21 20 20 26 13 15 0 0 0 0 0 0
Totale 327